 | • レポートコード：MRC2102QY12098 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、146ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界の受容体チロシンプロテインキナーゼERBB3市場について種類別（BA-0702、CDX-3379、Elgemtumab、ETBX-031、その他）、用途別（非小細胞癌、固形腫瘍、黒色腫、結腸直腸癌、その他）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・受容体チロシンプロテインキナーゼERBB3市場の概要 ・世界の主要地域別受容体チロシンプロテインキナーゼERBB3市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の受容体チロシンプロテインキナーゼERBB3市場規模2015-2026：種類別（BA-0702、CDX-3379、Elgemtumab、ETBX-031、その他） ・世界の受容体チロシンプロテインキナーゼERBB3市場規模2015-2026：用途別（非小細胞癌、固形腫瘍、黒色腫、結腸直腸癌、その他） ・受容体チロシンプロテインキナーゼERBB3の米国市場規模2015-2020 ・受容体チロシンプロテインキナーゼERBB3のヨーロッパ市場規模2015-2020 ・受容体チロシンプロテインキナーゼERBB3の中国市場規模2015-2020 ・受容体チロシンプロテインキナーゼERBB3の日本市場規模2015-2020 ・受容体チロシンプロテインキナーゼERBB3の東南アジア市場規模2015-2020 ・受容体チロシンプロテインキナーゼERBB3のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・受容体チロシンプロテインキナーゼERBB3の製造コスト分析 ・販売チャネル、流通業者、顧客 ・受容体チロシンプロテインキナーゼERBB3の市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Receptor Tyrosine Protein Kinase ERBB 3 Market
The global Receptor Tyrosine Protein Kinase ERBB 3 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Receptor Tyrosine Protein Kinase ERBB 3 Scope and Market Size
The global Receptor Tyrosine Protein Kinase ERBB 3 market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Receptor Tyrosine Protein Kinase ERBB 3 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Receptor Tyrosine Protein Kinase ERBB 3 market is segmented into
BA-0702
CDX-3379
Elgemtumab
ETBX-031
Others
Segment by Application, the Receptor Tyrosine Protein Kinase ERBB 3 market is segmented into
Non-Small Cell Carcinoma
Solid Tumor
Melanoma
Colorectal Cancer
Others
The Receptor Tyrosine Protein Kinase ERBB 3 market is analysed and market size information is provided by regions (countries). Segment by Application, the Receptor Tyrosine Protein Kinase ERBB 3 market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Receptor Tyrosine Protein Kinase ERBB 3 Market Share Analysis
Receptor Tyrosine Protein Kinase ERBB 3 market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Receptor Tyrosine Protein Kinase ERBB 3 business, the date to enter into the Receptor Tyrosine Protein Kinase ERBB 3 market, Receptor Tyrosine Protein Kinase ERBB 3 product introduction, recent developments, etc.
The major vendors covered:
AstraZeneca Plc
AVEO Pharmaceuticals, Inc.
Etubics Corporation
F. Hoffmann-La Roche Ltd.
GamaMabs Pharma S.A.
GlaxoSmithKline Plc
Hanmi Pharmaceuticals, Co. Ltd.
ImmunoGen, Inc.
Kolltan Pharmaceuticals, Inc.
Merrimack Pharmaceuticals, Inc.
Merus B.V.
Novartis AG
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Sihuan Pharmaceutical Holdings Group Ltd.
Sorrento Therapeutics, Inc.
Symphogen A/S
Takis S.r.l.
1 Receptor Tyrosine Protein Kinase ERBB 3 Market Overview
1.1 Receptor Tyrosine Protein Kinase ERBB 3 Product Scope
1.2 Receptor Tyrosine Protein Kinase ERBB 3 Segment by Type
1.2.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Type (2020-2026)
1.2.2 BA-0702
1.2.3 CDX-3379
1.2.4 Elgemtumab
1.2.5 ETBX-031
1.2.6 Others
1.3 Receptor Tyrosine Protein Kinase ERBB 3 Segment by Application
1.3.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Comparison by Application (2020-2026)
1.3.2 Non-Small Cell Carcinoma
1.3.3 Solid Tumor
1.3.4 Melanoma
1.3.5 Colorectal Cancer
1.3.6 Others
1.4 Receptor Tyrosine Protein Kinase ERBB 3 Market Estimates and Forecasts (2015-2026)
1.4.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Growth Rate (2015-2026)
1.4.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue and Growth Rate (2015-2026)
1.4.3 Global Receptor Tyrosine Protein Kinase ERBB 3 Price Trends (2015-2026)
2 Receptor Tyrosine Protein Kinase ERBB 3 Estimate and Forecast by Region
2.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Region (2015-2020)
2.2.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Region (2015-2020)
2.3 Global Receptor Tyrosine Protein Kinase ERBB 3 Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Receptor Tyrosine Protein Kinase ERBB 3 Estimates and Projections (2015-2026)
2.4.2 Europe Receptor Tyrosine Protein Kinase ERBB 3 Estimates and Projections (2015-2026)
2.4.3 China Receptor Tyrosine Protein Kinase ERBB 3 Estimates and Projections (2015-2026)
2.4.4 Japan Receptor Tyrosine Protein Kinase ERBB 3 Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Receptor Tyrosine Protein Kinase ERBB 3 Estimates and Projections (2015-2026)
2.4.6 India Receptor Tyrosine Protein Kinase ERBB 3 Estimates and Projections (2015-2026)
3 Global Receptor Tyrosine Protein Kinase ERBB 3 Competition Landscape by Players
3.1 Global Top Receptor Tyrosine Protein Kinase ERBB 3 Players by Sales (2015-2020)
3.2 Global Top Receptor Tyrosine Protein Kinase ERBB 3 Players by Revenue (2015-2020)
3.3 Global Receptor Tyrosine Protein Kinase ERBB 3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Receptor Tyrosine Protein Kinase ERBB 3 as of 2019)
3.4 Global Receptor Tyrosine Protein Kinase ERBB 3 Average Price by Company (2015-2020)
3.5 Manufacturers Receptor Tyrosine Protein Kinase ERBB 3 Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Receptor Tyrosine Protein Kinase ERBB 3 Players (Opinion Leaders)
4 Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size by Type
4.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Historic Market Review by Type (2015-2020)
4.1.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Type (2015-2020)
4.1.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Type (2015-2020)
4.1.3 Global Receptor Tyrosine Protein Kinase ERBB 3 Price by Type (2015-2020)
4.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Forecast by Type (2021-2026)
4.2.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Forecast by Type (2021-2026)
4.2.3 Global Receptor Tyrosine Protein Kinase ERBB 3 Price Forecast by Type (2021-2026)
5 Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size by Application
5.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Historic Market Review by Application (2015-2020)
5.1.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Application (2015-2020)
5.1.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Application (2015-2020)
5.1.3 Global Receptor Tyrosine Protein Kinase ERBB 3 Price by Application (2015-2020)
5.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Forecast by Application (2021-2026)
5.2.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Forecast by Application (2021-2026)
5.2.3 Global Receptor Tyrosine Protein Kinase ERBB 3 Price Forecast by Application (2021-2026)
6 United States Receptor Tyrosine Protein Kinase ERBB 3 Market Facts & Figures
6.1 United States Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Company (2015-2020)
6.2 United States Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Type (2015-2020)
6.3 United States Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Application (2015-2020)
7 Europe Receptor Tyrosine Protein Kinase ERBB 3 Market Facts & Figures
7.1 Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Company (2015-2020)
7.2 Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Type (2015-2020)
7.3 Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Application (2015-2020)
8 China Receptor Tyrosine Protein Kinase ERBB 3 Market Facts & Figures
8.1 China Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Company (2015-2020)
8.2 China Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Type (2015-2020)
8.3 China Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Application (2015-2020)
9 Japan Receptor Tyrosine Protein Kinase ERBB 3 Market Facts & Figures
9.1 Japan Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Company (3015-3030)
9.2 Japan Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Type (2015-2020)
9.3 Japan Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Application (2015-2020)
10 Southeast Asia Receptor Tyrosine Protein Kinase ERBB 3 Market Facts & Figures
10.1 Southeast Asia Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Application (2015-2020)
11 India Receptor Tyrosine Protein Kinase ERBB 3 Market Facts & Figures
11.1 India Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Company (2015-2020)
11.2 India Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Type (2015-2020)
11.3 India Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Receptor Tyrosine Protein Kinase ERBB 3 Business
12.1 AstraZeneca Plc
12.1.1 AstraZeneca Plc Corporation Information
12.1.2 AstraZeneca Plc Business Overview
12.1.3 AstraZeneca Plc Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue and Gross Margin (2015-2020)
12.1.4 AstraZeneca Plc Receptor Tyrosine Protein Kinase ERBB 3 Products Offered
12.1.5 AstraZeneca Plc Recent Development
12.2 AVEO Pharmaceuticals, Inc.
12.2.1 AVEO Pharmaceuticals, Inc. Corporation Information
12.2.2 AVEO Pharmaceuticals, Inc. Business Overview
12.2.3 AVEO Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue and Gross Margin (2015-2020)
12.2.4 AVEO Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Products Offered
12.2.5 AVEO Pharmaceuticals, Inc. Recent Development
12.3 Etubics Corporation
12.3.1 Etubics Corporation Corporation Information
12.3.2 Etubics Corporation Business Overview
12.3.3 Etubics Corporation Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Etubics Corporation Receptor Tyrosine Protein Kinase ERBB 3 Products Offered
12.3.5 Etubics Corporation Recent Development
12.4 F. Hoffmann-La Roche Ltd.
12.4.1 F. Hoffmann-La Roche Ltd. Corporation Information
12.4.2 F. Hoffmann-La Roche Ltd. Business Overview
12.4.3 F. Hoffmann-La Roche Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue and Gross Margin (2015-2020)
12.4.4 F. Hoffmann-La Roche Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Products Offered
12.4.5 F. Hoffmann-La Roche Ltd. Recent Development
12.5 GamaMabs Pharma S.A.
12.5.1 GamaMabs Pharma S.A. Corporation Information
12.5.2 GamaMabs Pharma S.A. Business Overview
12.5.3 GamaMabs Pharma S.A. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue and Gross Margin (2015-2020)
12.5.4 GamaMabs Pharma S.A. Receptor Tyrosine Protein Kinase ERBB 3 Products Offered
12.5.5 GamaMabs Pharma S.A. Recent Development
12.6 GlaxoSmithKline Plc
12.6.1 GlaxoSmithKline Plc Corporation Information
12.6.2 GlaxoSmithKline Plc Business Overview
12.6.3 GlaxoSmithKline Plc Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue and Gross Margin (2015-2020)
12.6.4 GlaxoSmithKline Plc Receptor Tyrosine Protein Kinase ERBB 3 Products Offered
12.6.5 GlaxoSmithKline Plc Recent Development
12.7 Hanmi Pharmaceuticals, Co. Ltd.
12.7.1 Hanmi Pharmaceuticals, Co. Ltd. Corporation Information
12.7.2 Hanmi Pharmaceuticals, Co. Ltd. Business Overview
12.7.3 Hanmi Pharmaceuticals, Co. Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Hanmi Pharmaceuticals, Co. Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Products Offered
12.7.5 Hanmi Pharmaceuticals, Co. Ltd. Recent Development
12.8 ImmunoGen, Inc.
12.8.1 ImmunoGen, Inc. Corporation Information
12.8.2 ImmunoGen, Inc. Business Overview
12.8.3 ImmunoGen, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue and Gross Margin (2015-2020)
12.8.4 ImmunoGen, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Products Offered
12.8.5 ImmunoGen, Inc. Recent Development
12.9 Kolltan Pharmaceuticals, Inc.
12.9.1 Kolltan Pharmaceuticals, Inc. Corporation Information
12.9.2 Kolltan Pharmaceuticals, Inc. Business Overview
12.9.3 Kolltan Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Kolltan Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Products Offered
12.9.5 Kolltan Pharmaceuticals, Inc. Recent Development
12.10 Merrimack Pharmaceuticals, Inc.
12.10.1 Merrimack Pharmaceuticals, Inc. Corporation Information
12.10.2 Merrimack Pharmaceuticals, Inc. Business Overview
12.10.3 Merrimack Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Merrimack Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Products Offered
12.10.5 Merrimack Pharmaceuticals, Inc. Recent Development
12.11 Merus B.V.
12.11.1 Merus B.V. Corporation Information
12.11.2 Merus B.V. Business Overview
12.11.3 Merus B.V. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Merus B.V. Receptor Tyrosine Protein Kinase ERBB 3 Products Offered
12.11.5 Merus B.V. Recent Development
12.12 Novartis AG
12.12.1 Novartis AG Corporation Information
12.12.2 Novartis AG Business Overview
12.12.3 Novartis AG Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Novartis AG Receptor Tyrosine Protein Kinase ERBB 3 Products Offered
12.12.5 Novartis AG Recent Development
12.13 Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
12.13.1 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Corporation Information
12.13.2 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Business Overview
12.13.3 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Products Offered
12.13.5 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Recent Development
12.14 Sihuan Pharmaceutical Holdings Group Ltd.
12.14.1 Sihuan Pharmaceutical Holdings Group Ltd. Corporation Information
12.14.2 Sihuan Pharmaceutical Holdings Group Ltd. Business Overview
12.14.3 Sihuan Pharmaceutical Holdings Group Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Sihuan Pharmaceutical Holdings Group Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Products Offered
12.14.5 Sihuan Pharmaceutical Holdings Group Ltd. Recent Development
12.15 Sorrento Therapeutics, Inc.
12.15.1 Sorrento Therapeutics, Inc. Corporation Information
12.15.2 Sorrento Therapeutics, Inc. Business Overview
12.15.3 Sorrento Therapeutics, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Sorrento Therapeutics, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Products Offered
12.15.5 Sorrento Therapeutics, Inc. Recent Development
12.16 Symphogen A/S
12.16.1 Symphogen A/S Corporation Information
12.16.2 Symphogen A/S Business Overview
12.16.3 Symphogen A/S Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Symphogen A/S Receptor Tyrosine Protein Kinase ERBB 3 Products Offered
12.16.5 Symphogen A/S Recent Development
12.17 Takis S.r.l.
12.17.1 Takis S.r.l. Corporation Information
12.17.2 Takis S.r.l. Business Overview
12.17.3 Takis S.r.l. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue and Gross Margin (2015-2020)
12.17.4 Takis S.r.l. Receptor Tyrosine Protein Kinase ERBB 3 Products Offered
12.17.5 Takis S.r.l. Recent Development
13 Receptor Tyrosine Protein Kinase ERBB 3 Manufacturing Cost Analysis
13.1 Receptor Tyrosine Protein Kinase ERBB 3 Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Receptor Tyrosine Protein Kinase ERBB 3
13.4 Receptor Tyrosine Protein Kinase ERBB 3 Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Receptor Tyrosine Protein Kinase ERBB 3 Distributors List
14.3 Receptor Tyrosine Protein Kinase ERBB 3 Customers
15 Market Dynamics
15.1 Receptor Tyrosine Protein Kinase ERBB 3 Market Trends
15.2 Receptor Tyrosine Protein Kinase ERBB 3 Opportunities and Drivers
15.3 Receptor Tyrosine Protein Kinase ERBB 3 Market Challenges
15.4 Receptor Tyrosine Protein Kinase ERBB 3 Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Receptor Tyrosine Protein Kinase ERBB 3 Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs) by Region (2015-2020)
Table 5. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Region (2015-2020)
Table 6. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Share by Region (2015-2020)
Table 8. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs) Forecast by Region (2021-2026)
Table 9. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Share Forecast by Region (2021-2026)
Table 12. Global Receptor Tyrosine Protein Kinase ERBB 3 (K Pcs) of Key Companies (2015-2020)
Table 13. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Share by Company (2015-2020)
Table 14. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Share by Company (2015-2020)
Table 16. Global Receptor Tyrosine Protein Kinase ERBB 3 by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Receptor Tyrosine Protein Kinase ERBB 3 as of 2019)
Table 17. Global Receptor Tyrosine Protein Kinase ERBB 3 Average Price (USD/Pcs) of Key Company (2015-2020)
Table 18. Manufacturers Receptor Tyrosine Protein Kinase ERBB 3 Manufacturing Sites and Area Served
Table 19. Manufacturers Receptor Tyrosine Protein Kinase ERBB 3 Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Receptor Tyrosine Protein Kinase ERBB 3 Players
Table 22. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs) by Type (2015-2020)
Table 23. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Share by Type (2015-2020)
Table 24. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Receptor Tyrosine Protein Kinase ERBB 3 Price (K Pcs) by Type (2015-2020)
Table 26. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Share by Type (2021-2026)
Table 27. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Share by Type (2021-2026)
Table 29. Global Receptor Tyrosine Protein Kinase ERBB 3 Price (K Pcs) by Type (2021-2026)
Table 30. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs) by Application (2015-2020)
Table 31. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Share by Application (2015-2020)
Table 32. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Receptor Tyrosine Protein Kinase ERBB 3 Price (K Pcs) by Application (2015-2020)
Table 34. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs) by Application (2021-2026)
Table 35. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Share by Application (2021-2026)
Table 36. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Share by Application (2021-2026)
Table 38. Global Receptor Tyrosine Protein Kinase ERBB 3 Price (K Pcs) by Application (2021-2026)
Table 39. United States Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs) by Company (2015-2020)
Table 40. United States Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Company (2015-2020)
Table 41. United States Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs) by Type (2015-2020)
Table 42. United States Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Type (2015-2020)
Table 43. United States Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs) by Application (2015-2020)
Table 44. United States Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Application (2015-2020)
Table 45. Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs) by Company (2015-2020)
Table 46. Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Company (2015-2020)
Table 47. Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs) by Type (2015-2020)
Table 48. Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Type (2015-2020)
Table 49. Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs) by Application (2015-2020)
Table 50. Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Type (2015-2020)
Table 51. China Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs) by Company (2015-2020)
Table 52. China Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Company (2015-2020)
Table 53. China Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs) by Type (2015-2020)
Table 54. China Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Type (2015-2020)
Table 55. China Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs) by Application (2015-2020)
Table 56. China Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Application (2015-2020)
Table 57. Japan Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs) by Company (2015-2020)
Table 58. Japan Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Company (2015-2020)
Table 59. Japan Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs) by Type (2015-2020)
Table 60. Japan Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Type (2015-2020)
Table 61. Japan Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs) by Application (2015-2020)
Table 62. Japan Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs) by Company (2015-2020)
Table 64. Southeast Asia Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs) by Type (2015-2020)
Table 66. Southeast Asia Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs) by Type (2015-2020)
Table 68. Southeast Asia Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Application (2015-2020)
Table 69. India Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs) by Company (2015-2020)
Table 70. India Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Company (2015-2020)
Table 71. India Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs) by Type (2015-2020)
Table 72. India Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Type (2015-2020)
Table 73. India Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs) by Application (2015-2020)
Table 74. India Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Application (2015-2020)
Table 75. AstraZeneca Plc Corporation Information
Table 76. AstraZeneca Plc Description and Business Overview
Table 77. AstraZeneca Plc Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 78. AstraZeneca Plc Receptor Tyrosine Protein Kinase ERBB 3 Product
Table 79. AstraZeneca Plc Recent Development
Table 80. AVEO Pharmaceuticals, Inc. Corporation Information
Table 81. AVEO Pharmaceuticals, Inc. Description and Business Overview
Table 82. AVEO Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. AVEO Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Product
Table 84. AVEO Pharmaceuticals, Inc. Recent Development
Table 85. Etubics Corporation Corporation Information
Table 86. Etubics Corporation Description and Business Overview
Table 87. Etubics Corporation Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 88. Etubics Corporation Receptor Tyrosine Protein Kinase ERBB 3 Product
Table 89. Etubics Corporation Recent Development
Table 90. F. Hoffmann-La Roche Ltd. Corporation Information
Table 91. F. Hoffmann-La Roche Ltd. Description and Business Overview
Table 92. F. Hoffmann-La Roche Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 93. F. Hoffmann-La Roche Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Product
Table 94. F. Hoffmann-La Roche Ltd. Recent Development
Table 95. GamaMabs Pharma S.A. Corporation Information
Table 96. GamaMabs Pharma S.A. Description and Business Overview
Table 97. GamaMabs Pharma S.A. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 98. GamaMabs Pharma S.A. Receptor Tyrosine Protein Kinase ERBB 3 Product
Table 99. GamaMabs Pharma S.A. Recent Development
Table 100. GlaxoSmithKline Plc Corporation Information
Table 101. GlaxoSmithKline Plc Description and Business Overview
Table 102. GlaxoSmithKline Plc Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 103. GlaxoSmithKline Plc Receptor Tyrosine Protein Kinase ERBB 3 Product
Table 104. GlaxoSmithKline Plc Recent Development
Table 105. Hanmi Pharmaceuticals, Co. Ltd. Corporation Information
Table 106. Hanmi Pharmaceuticals, Co. Ltd. Description and Business Overview
Table 107. Hanmi Pharmaceuticals, Co. Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 108. Hanmi Pharmaceuticals, Co. Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Product
Table 109. Hanmi Pharmaceuticals, Co. Ltd. Recent Development
Table 110. ImmunoGen, Inc. Corporation Information
Table 111. ImmunoGen, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 112. ImmunoGen, Inc. Description and Business Overview
Table 113. ImmunoGen, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Product
Table 114. ImmunoGen, Inc. Recent Development
Table 115. Kolltan Pharmaceuticals, Inc. Corporation Information
Table 116. Kolltan Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 117. Kolltan Pharmaceuticals, Inc. Description and Business Overview
Table 118. Kolltan Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Product
Table 119. Kolltan Pharmaceuticals, Inc. Recent Development
Table 120. Merrimack Pharmaceuticals, Inc. Corporation Information
Table 121. Merrimack Pharmaceuticals, Inc. Description and Business Overview
Table 122. Merrimack Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 123. Merrimack Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Product
Table 124. Merrimack Pharmaceuticals, Inc. Recent Development
Table 125. Merus B.V. Corporation Information
Table 126. Merus B.V. Description and Business Overview
Table 127. Merus B.V. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 128. Merus B.V. Receptor Tyrosine Protein Kinase ERBB 3 Product
Table 129. Merus B.V. Recent Development
Table 130. Novartis AG Corporation Information
Table 131. Novartis AG Description and Business Overview
Table 132. Novartis AG Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 133. Novartis AG Receptor Tyrosine Protein Kinase ERBB 3 Product
Table 134. Novartis AG Recent Development
Table 135. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Corporation Information
Table 136. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Description and Business Overview
Table 137. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 138. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Product
Table 139. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Recent Development
Table 140. Sihuan Pharmaceutical Holdings Group Ltd. Corporation Information
Table 141. Sihuan Pharmaceutical Holdings Group Ltd. Description and Business Overview
Table 142. Sihuan Pharmaceutical Holdings Group Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 143. Sihuan Pharmaceutical Holdings Group Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Product
Table 144. Sihuan Pharmaceutical Holdings Group Ltd. Recent Development
Table 145. Sorrento Therapeutics, Inc. Corporation Information
Table 146. Sorrento Therapeutics, Inc. Description and Business Overview
Table 147. Sorrento Therapeutics, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 148. Sorrento Therapeutics, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Product
Table 149. Sorrento Therapeutics, Inc. Recent Development
Table 150. Symphogen A/S Corporation Information
Table 151. Symphogen A/S Description and Business Overview
Table 152. Symphogen A/S Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 153. Symphogen A/S Receptor Tyrosine Protein Kinase ERBB 3 Product
Table 154. Symphogen A/S Recent Development
Table 155. Takis S.r.l. Corporation Information
Table 156. Takis S.r.l. Description and Business Overview
Table 157. Takis S.r.l. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 158. Takis S.r.l. Receptor Tyrosine Protein Kinase ERBB 3 Product
Table 159. Takis S.r.l. Recent Development
Table 160. Production Base and Market Concentration Rate of Raw Material
Table 161. Key Suppliers of Raw Materials
Table 162. Receptor Tyrosine Protein Kinase ERBB 3 Distributors List
Table 163. Receptor Tyrosine Protein Kinase ERBB 3 Customers List
Table 164. Receptor Tyrosine Protein Kinase ERBB 3 Market Key Trends
Table 165. Receptor Tyrosine Protein Kinase ERBB 3 Key Opportunities and Drivers
Table 166. Receptor Tyrosine Protein Kinase ERBB 3 Market Challenges
Table 167. Research Programs/Design for This Report
Table 168. Key Data Information from Secondary Sources
Table 169. Key Data Information from Primary Sources
List of Figures
Figure 1. Receptor Tyrosine Protein Kinase ERBB 3 Product Picture
Figure 2. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Receptor Tyrosine Protein Kinase ERBB 3 Market Share by Application in 2020 & 2026
Figure 6. Non-Small Cell Carcinoma Examples
Figure 7. Solid Tumor Examples
Figure 8. Melanoma Examples
Figure 9. Colorectal Cancer Examples
Figure 10. Others Examples
Figure 11. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs) Growth Rate (2015-2026)
Figure 12. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue (US$ Million) Growth Rate (2015-2026)
Figure 13. Global Receptor Tyrosine Protein Kinase ERBB 3 Price Trends Growth Rate (2015-2026) (USD/Pcs)
Figure 14. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Region: 2015 VS 2020
Figure 15. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Region: 2021 VS 2026
Figure 16. United States Receptor Tyrosine Protein Kinase ERBB 3 Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. United States Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs) Growth Rate (2015-2026)
Figure 18. Europe Receptor Tyrosine Protein Kinase ERBB 3 Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales (Million USD) Growth Rate (2015-2026)
Figure 20. China Receptor Tyrosine Protein Kinase ERBB 3 Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. China Receptor Tyrosine Protein Kinase ERBB 3 Sales (Million USD) and Growth Rate (2015-2026)
Figure 22. Japan Receptor Tyrosine Protein Kinase ERBB 3 Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Japan Receptor Tyrosine Protein Kinase ERBB 3 Sales (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Receptor Tyrosine Protein Kinase ERBB 3 Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. Southeast Asia Receptor Tyrosine Protein Kinase ERBB 3 Sales (Million USD) Growth Rate (2015-2026)
Figure 26. India Receptor Tyrosine Protein Kinase ERBB 3 Revenue (Million USD) Growth Rate (2015-2026)
Figure 27. India Receptor Tyrosine Protein Kinase ERBB 3 Sales (Million USD) Growth Rate (2015-2026)
Figure 28. Global 5 Largest Receptor Tyrosine Protein Kinase ERBB 3 Players Market Share by Revenue in Receptor Tyrosine Protein Kinase ERBB 3 2015 & 2019
Figure 29. Receptor Tyrosine Protein Kinase ERBB 3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 30. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Share by Type (2015-2020)
Figure 31. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Growth Rate by Type in 2015 & 2019
Figure 32. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Share by Application (2015-2020)
Figure 33. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Growth Rate by Application in 2015 & 2019
Figure 34. United States Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Type in 2019
Figure 35. United States Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Type in 2019
Figure 36. Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Company in 2019
Figure 37. Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Type in 2019
Figure 38. Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Application in 2019
Figure 39. China Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Company in 2019
Figure 40. China Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Type in 2019
Figure 41. China Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Application in 2019
Figure 42. Japan Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Company in 2019
Figure 43. Japan Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Type in 2019
Figure 44. Japan Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Application in 2019
Figure 45. Southeast Asia Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Company in 2019
Figure 46. Southeast Asia Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Type in 2019
Figure 47. Southeast Asia Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Application in 2019
Figure 48. India Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Company in 2019
Figure 49. India Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Type in 2019
Figure 50. India Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Application in 2019
Figure 51. Key Raw Materials Price Trend
Figure 52. Manufacturing Cost Structure of Receptor Tyrosine Protein Kinase ERBB 3
Figure 53. Manufacturing Process Analysis of Receptor Tyrosine Protein Kinase ERBB 3
Figure 54. Receptor Tyrosine Protein Kinase ERBB 3 Industrial Chain Analysis
Figure 55. Channels of Distribution
Figure 56. Distributors Profiles
Figure 57. Porter's Five Forces Analysis
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
非受容体型チロシンプロテインホスファターゼ1の世界市場レポート2020 Market Analysis and Insights: Global Tyrosine Protein Phosphatase Non Receptor Type 1 Market The global Tyrosine Protein Phosphatase Non Receptor Type 1 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Tyrosine Protein P…- チロシンキナーゼJAK阻害剤の世界市場レポート2020 Janus kinase inhibitors, also known as JAK inhibitors or jakinibs, are a type of medication that functions by inhibiting the activity of one or more of the Janus kinase family of enzymes (JAK1, JAK2, JAK3, TYK2), thereby interfering with the JAK-STAT signaling pathway. These inhibitors have therapeu…
- プロテインキナーゼ阻害剤の世界市場レポート2020 Market Analysis and Insights: Global Protein Kinase Inhibitor Market The global Protein Kinase Inhibitor market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Protein Kinase Inhibitor Scope and Market Size The global Protein …
- 非チロシンキナーゼ阻害剤の世界市場レポート2020 Market Analysis and Insights: Global Non-Tyrosine Kinase Inhibitors Market The global Non-Tyrosine Kinase Inhibitors market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Non-Tyrosine Kinase Inhibitors Scope and Market Size T…
- Rho関連プロテインキナーゼ1の世界市場レポート2020 Market Analysis and Insights: Global Rho Associated Protein Kinase 1 Market The global Rho Associated Protein Kinase 1 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Rho Associated Protein Kinase 1 Scope and Market Siz…